Differentially expressed downstream genes in cells with normal or mutated p53

Oncol Res. 2003;13(6-10):429-36. doi: 10.3727/096504003108748456.

Abstract

Mutations in p53 gene could lead to loss of function, negative complementation, or to gain-of-oncogenic functions, thus leading to the increase of tumorigenicity and invasiveness of cancer. This study focused on cancer-related p53 mutants, including A138T, C141Y, RI58L, G245C, and R248Q. Using a modified differential display technique, response profiles of plasmid-expressed wild-type as well as mutated p53, in comparison to p53-null cells, are being established. These profiles can help our understanding of p53 involvement in cancer, leading to accurate diagnosis, treatment, and prognostic analysis by: 1) comprehensive knowledge of p53 network gene expression profiles; 2) finding the most significant gene expression profiles of p53 mutants; 3) revealing genes that only respond to p53 mutants (gain of function). Our results showed significant differences in the expression patterns among p53-null. wild-type p53, and p53 mutants A138T, C141Y, R158L, G245C, and R248Q samples. We also report here the first found p53 mutant-triggered alternative splicing.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing / genetics
  • Gene Expression Profiling*
  • Gene Expression Regulation, Neoplastic / genetics*
  • Genes, p53 / genetics*
  • Humans
  • Mutagenesis, Site-Directed*
  • Mutation
  • Osteosarcoma / genetics
  • Sequence Analysis
  • Transcriptional Activation
  • Tumor Cells, Cultured